Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

Abstract Background One quarter to one third of patients eligible for systemic thrombolysis are on antiplatelet therapy at presentation. In this study, we aimed to assess the safety and efficacy of intravenous thrombolysis in stroke patients on prescribed antiplatelet therapy in the WAKE-UP trial. M...

Full description

Bibliographic Details
Main Authors: Benedikt M. Frey, Florent Boutitie, Bastian Cheng, Tae-Hee Cho, Martin Ebinger, Matthias Endres, Jochen B. Fiebach, Jens Fiehler, Ian Ford, Ivana Galinovic, Alina Königsberg, Josep Puig, Pascal Roy, Anke Wouters, Tim Magnus, Vincent Thijs, Robin Lemmens, Keith W. Muir, Norbert Nighoghossian, Salvador Pedraza, Claus Z. Simonsen, Christian Gerloff, Götz Thomalla, on behalf of the WAKE-UP investigators
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Neurological Research and Practice
Subjects:
Ischemic stroke
Alteplase
Thrombolysis
Recombinant human tissue plasminogen activator
Rt-PA
Aspirin
Online Access:http://link.springer.com/article/10.1186/s42466-020-00087-9

Internet

http://link.springer.com/article/10.1186/s42466-020-00087-9

Similar Items